Financials

  • Market Capitalization 2.12 B
  • Employee 325
  • Founded 2006
  • CEO Pravin Dugel
  • Website www.ocutx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BZV0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.88
Rapporto prezzo/fatturato
30.69

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1931
MESO
Mesoblast Limited - American Depositary Shares
16.74 USD+3.21%+20.78%+21.04%+48.93%2.14 B USD
1932
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
24.13 USD+5.42%+5.00%+30.36%+162.00%2.14 B USD
1958
ATAI
AtaiBeckley Inc. - Common Stock
5.67 USD+14.08%+10.96%+47.66%+43.54%2.09 B USD
1968
ABCL
AbCellera Biologics Inc. - Common Shares
6.74 USD+3.37%-8.80%+28.87%+69.77%2.06 B USD

Notizie